MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Explore how genetic testing aids in diagnosing Arrhythmogenic Right Ventricular Cardiomyopathy, offering insights into early detection, risk assessment, and personalized care.
Explore how genetic testing aids in diagnosing ARC syndrome, a rare genetic disorder, by identifying crucial gene mutations for targeted treatment and family planning.
Explore how genetic testing aids in diagnosing and treating anaplastic astrocytoma by identifying mutations, personalizing plans, and monitoring progression.
Understand ATR-X-related syndrome and its symptoms. Explore how genetic testing aids in early diagnosis, personalized treatment, and monitors disease progression.
Genetic testing revolutionizes aHUS diagnosis by identifying mutations, personalizing treatment, predicting prognosis, and aiding family planning strategies.
Explore the crucial role of genetic testing in diagnosing atypical Rett syndrome. Learn about gene mutations, treatment strategies, and the importance of MRI imaging.
Explore the impact of genetic testing on diagnosing and managing Autosomal Dominant CMT2M, enhancing early detection, personalized treatments, and family planning.
Uncover how genetic testing aids in diagnosing autosomal dominant hyperinsulinism due to SUR1 deficiency, leading to personalized treatment and informed family planning.